Expert Perspectives on CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer

Press/Media: Press / Media

PeriodDec 18 2018

Media coverage

1

Media coverage

  • TitleExpert Perspectives on CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer
    Media name/outletClinical Care Options for HIV
    CountryUnited States
    Date12/18/18
    PersonsVirginia G Kaklamani